MedPath
FDA Product

Anticoagulant Citrate Dextrose (ACD-A)

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Anticoagulant Citrate Dextrose (ACD-A)

14537-820

Regulatory Information

14537-820

BA110057

C73584

July 28, 2023

USA

These highlights do not include all the information needed to use ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A safely and effectively. See full prescribing information for ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A. ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A Sterile Fluid Polyolefin Container (solution bag) Clear Overwrap Initial U.S. Approval: 2012

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

Terumo BCT, Ltd

233649834

Active Ingredients

Dextrose Monohydrate

Quantity: 0.245 g in 10 mL

Code: LX22YL083G

Class Code: ACTIB

Citric Acid Monohydrate

Quantity: 0.08 g in 10 mL

Code: 2968PHW8QP

Class Code: ACTIM

Sodium Citrate, Unspecified Form

Quantity: 0.220 g in 10 mL

Code: 1Q73Q2JULR

Class Code: ACTIB

Water

Code: 059QF0KO0R

Class Code: IACT

Active Moieties

Anhydrous Dextrose

Code: 5SL0G7R0OK

Sodium Cation

Code: LYR4M0NH37

Anhydrous Citric Acid

Code: XF417D3PSL

© Copyright 2025. All Rights Reserved by MedPath